Biosurgery is a medical procedure that uses natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. It is extensively utilized to prevent excessive blood loss, provide adhesion for wound or tissue sealing, repair damaged bones and tissues, etc. Biosurgeries are generally conducted through hemostatic, sealant, bone graft substitute, adhesion prevention, soft tissue repair, and staple line reinforcement products. They also use natural allografts, xenografts, and cultured epithelial autografts to minimize intra- and post-operative complications and promote faster recovery of patients. Consequently, biosurgical processes are widely adopted in several surgeries, including neurological, orthopedic, spinal, reconstruction, cardiovascular, etc

Biosurgery Market Trends:

The escalating incidences of musculoskeletal disorders are primarily driving the biosurgery market. Moreover, the expanding geriatric population, who are more prone to chronic medical ailments, such as osteoporosis, is further catalyzing the market growth. Besides this, numerous healthcare providers are increasingly adopting biosurgeries for effectively managing blood loss in patients with surgical sealants and minimally invasive (MI) hemostatic agents instead of conventionally used sutures and staples. This, in turn, is acting as another significant growth-inducing factor. Furthermore, the growing incidences of sports-related injuries and accidental traumas are also augmenting the global market. Apart from this, the development of plasma-based, multi-functional, and multi-use products for these surgical processes is anticipated to stimulate the biosurgery market in the coming years.

Request Free Sample Report: https://www.imarcgroup.com/biosurgery-market/requestsample

Biosurgery Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.

The report has segmented the market on the basis on region, disc type, material type and end user.

Breakup by Product:

Bone-Graft Substitutes

Soft-Tissue Attachments

Hemostatic Agents

Surgical Sealants and Adhesives

Adhesion Barriers

Staple Line Reinforcement

Breakup by Source:

Natural/Biologics Products

Synthetic Products

Breakup by Application:

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Gynecological Surgery

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/biosurgery-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide.